Sartorius | SRT3 - Operating Profit

Stock Price
233.30
Daily Change
5.00 2.19%
Monthly
-10.27%
Yearly
-1.73%
Q1 Forecast
230.71

Sartorius reported EUR150.1M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sartorius EUR 150.1M 11.7M Sep/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025